Regulus Therapeutics
1 follower
‌
Regulus Therapeutics Inc. (Nasdaq:RGLS) is a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs.
Industries
Headquarters
Employees
Links
Org chart
Jay Hagan
President & CEO
Jay Hagan
Collapse
Preston S. Klassen
President & Head of Reserach & Development
Cris Calsada
CFO
Curtis Monnig
VP & CMC
Christopher Aker
SVP & General Counsel
Rekha Garg
SVP, Clinical Development & Regulatory
Claire Padgett
SVP, Clinical Operations
Amin Kamel
VP, Drug Metabolism & Pharmacokinetics
Brian Campion
VP, Business Development
Moh Ahmadian
VP, Chemistry & Pharmaceutical Development
Edmund Lee
VP, Translational Medicine
